Highlights from this issue
The yin and the yang of immunosuppression with inhaled corticosteroids
IPF
Journal policy on research funded by the tobacco industry
Tuberculosis vaccines
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
Use of inhaled corticosteroids and the risk of tuberculosis
Linezolid for XDR-TB
Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis
Systemic tryptophan and kynurenine catabolite levels relate to severity of rhinovirus-induced asthma exacerbation
Imbalance between subpopulations of regulatory T cells in COPD
Increased skeletal muscle-specific microRNA in the blood of patients with COPD
Microbial communities in the respiratory tract of patients with interstitial lung disease
Airway inflammation in cystic fibrosis
Evaluating hypoxia during air travel in healthy infants
Thalidamide for IPF-associated cough
Systemic safety of fluticasone furoate/vilanterol combination
Authors’ reply to ‘Safety and tolerability of fluticasone furoate/vilanterol’
Asthma admissions, smoking bans and administrative databases
Asthma admissions, smoking bans and administrative databases
What is top of the charts? BPIFB1/LPLUNC1 localises to the bronchiolised epithelium in the honeycomb cysts in UIP
European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions
Migration and tuberculosis in the UK
The bird it was that died
Regulatory T cells and COPD
Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma
Improving care for patients with lung cancer in the UK
What's hot the other lot got